To include your compound in the COVID-19 Resource Center, submit it here.
Roche has rights to Tamiflu, a neuraminidase (NEU1; SIAL1) inhibitor, from Gilead Sciences Inc. (NASDAQ:GILD, Foster City, Calif.). Xeloda is an oral prodrug form of 5-fluorouracil (5-FU). Pegasys
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury